Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw
- 1 June 2014
- journal article
- Published by Elsevier BV in Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology
- Vol. 117 (6), e429-e435
- https://doi.org/10.1016/j.oooo.2012.08.442
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate ExposureJournal of Oral and Maxillofacial Surgery, 2010
- Bisphosphonate-associated osteonecrosis of the jaw: what do we currently know? A survey of knowledge given in the recent literatureClinical Oral Investigations, 2009
- Incidence of bisphosphonate‐associated osteonecrosis of the jaws in breast cancer patientsCancer, 2009
- Oral bisphosphonate use and the prevalence of osteonecrosis of the jawThe Journal of the American Dental Association, 2009
- Incidence of Osteonecrosis of the Jaw in Women With Postmenopausal Osteoporosis in the Health Outcomes and Reduced Incidence With Zoledronic Acid Once Yearly Pivotal Fracture TrialThe Journal of the American Dental Association, 2008
- Bisphosphonate Use and the Risk of Adverse Jaw OutcomesThe Journal of the American Dental Association, 2008
- Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonatesLeukemia & Lymphoma, 2008
- Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatmentThe Lancet Oncology, 2006
- Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 casesJournal of Oral and Maxillofacial Surgery, 2004
- Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemicJournal of Oral and Maxillofacial Surgery, 2003